Model
Edge
4D Molecular Therapeutics
0001834021
Filing Type
144
Filing Date
5/31/2026
Updated
6/1/26, 3:40 PM
Copy Ref
Filing
144
Earnings Release
Exhibits
144
Notice of Proposed Sale of Securities